Study investigator David Berg explains why volume overload shouldn't decide which hospitalized patients get an SGLT2 inhibitor.
|Videos|July 7, 2015
The Future of Mobile Health Programs
Author(s)Davy James, Managing Editor
Fiona Smythe, vice president of strategy at mscripts, discusses developing trends in mobile health care applications.
Advertisement
Fiona Smythe, vice president of strategy at mscripts, discusses developing trends in mobile health care applications.
Advertisement
Related to this article
Advertisement
Advertisement
Trending on Pharmacy Times
1
After 180 Years, Multiple Myeloma Gets a Definition of Cure
2
Armored CAR T-Cell Therapy Produces Durable Complete Response in Pediatric Solid Tumors
3
Not So Rare After All: Pharmacists Weigh In on Diagnosing and Managing ATTR-CM
4
Semaglutide Linked to Up to 40% Fewer Asthma Attacks, Real-World Data Show
5